Supply of oncology medicines in five lots

Summary

The specialist oncology hospital in Varna is procuring, in five lots, medicines reimbursed by Bulgaria’s National Health Insurance Fund separately from the prices of clinical pathways and procedures. The lots cover atezolizumab (562,500 mg), etoposide (60,000 mg), apalutamide (2,592,000 mg), and zolbetuximab in 100 mg (9,000 mg) and 300 mg (81,000 mg) presentations. Deliveries will be made against periodic orders over 24 months, with a possible extension of up to six months if the estimated value has not been reached and supplies are still needed; the total estimated value is EUR 2,298,100.